Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors

Immunotherapy represents the new era of cancer treatment because of its promising results in various cancer types. In urological tumors, the use of the immune-checkpoint inhibitors (ICIs) is increasingly spreading. Although not all patients and not all diseases respond equally well to immunotherapy,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Oncol
Main Authors: Schepisi, Giuseppe, Brighi, Nicole, Cursano, Maria Concetta, Gurioli, Giorgia, Ravaglia, Giorgia, Altavilla, Amelia, Burgio, Salvatore Luca, Testoni, Sara, Menna, Cecilia, Farolfi, Alberto, Casadei, Chiara, Tonini, Giuseppe, Santini, Daniele, De Giorgi, Ugo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6770345/
https://ncbi.nlm.nih.gov/pubmed/31641355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7317964
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados